In response to the Ebola outbreak, the Food and Drug Administration issued an emergency authorization for the use of two rapid tests to detect Ebola. The tests are manufactured by BioFire Defense LLC, a division of BioMerieux. The BioFire Defense FilmArray NGDS BT-E Assay is authorized for use by laboratories designated by the Department of […]
November 03, 2014 Intelligence: Late-Breaking Lab News
- By Robert Michel
- > From the Volume XXI No. 15 - November 3, 2014 Issue
